Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Giant Cell Arteritis Treatment Market: By Treatment Type: Corticosteroid Therapy, Adjuvant Agents; By End Use: Hospitals, Clinics, ASC’s, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Giant Cell Arteritis Treatment Market Outlook

The global giant cell arteritis treatment market is expected to grow in the forecast period of 2021-2026 at a CAGR of 5.8%.

 

North America Market to be Aided by the Increasing Prevalence of the Disease.

North America holds a significant share in the global market for giant cell arteritis treatment. This can be correlated to the rising incidences of the disease among the patients. Apart from North America, Europe is also a key market for giant cell arteritis treatment. The European market is being driven by the higher standards of living and health awareness among the consumers in the region. Meanwhile, the Asia Pacific market is expected to witness a healthy growth in the coming years as well. The growing developments and technological advancements in the healthcare industry in countries such as India and China are aiding the market growth in the Asia Pacific region.

 

Giant Cell Arteritis: Industry Definition and Segmentation

Giant cell arteritis (GCA), also known as temporal arteritis, is a disease of inflammation in large blood vessels, usually around the brain and head. Symptoms of GCA may include pain in the temples, flu, headache, double vision, and difficulty in opening the mouth. However, the causes of the disease are yet unknown.

Based on the treatment type, the market is broadly classified into:

  • Corticosteroid Therapy 
  • Adjuvant Agents

By end-use, the market can be categorized into:

  • Hospitals
  • Clinics
  • ASC’s
  • Others

The EMR report looks into the regional markets of giant cell arteritis treatment like North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

 

Growing Elderly Population Driving the Market Growth of Giant Cell Arteritis Treatment

The increasing prevalence of giant cell arteritis across the globe is driving the market for giant cell arteritis treatment. It is generally observed in the elderly population. The increasing disposable incomes, coupled with the rising aged population, are aiding the market growth. The increasing health awareness and improving standards of living in developing countries are adding to the market growth. Governments across the globe are investing huge amounts in research and development activities in the healthcare sector. The subsequent technological advancements and developments in the healthcare industry are anticipated to provide an impetus for the growth of the market. These factors are expected to propel the global market for giant cell arteritis treatment forward over the forecast period.

 

Key Industry Players in the Global Giant Cell Arteritis Treatment Market

The report presents a detailed analysis of the following key players in the global giant cell arteritis treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • The Johns Hopkins Hospital
  • American College of Rheumatology
  • Duke University Health System
  • Lahey Clinic Foundation, Inc.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Giant Cell Arteritis Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Giant Cell Arteritis Treatment Historical Market (2016-2020) 
    8.3    Global Giant Cell Arteritis Treatment Market Forecast (2021-2026)
    8.4    Global Giant Cell Arteritis Treatment Market by Treatment Type
        8.4.1    Corticosteroid Therapy
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Adjuvant Agents
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
    8.5    Global Giant Cell Arteritis Treatment Market by End Use
        8.5.1    Hospitals
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Clinics
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    ASC’s
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Others
    8.6    Global Giant Cell Arteritis Treatment Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Key Players
    12.3    Company Profiles
        12.3.1    The Johns Hopkins Hospital
            12.3.1.1    Company Overview
            12.3.1.2    Product Portfolio
            12.3.1.3    Demographic Reach and Achievements
            12.3.1.4    Certifications
        12.3.2    American College of Rheumatology
            12.3.2.1    Company Overview
            12.3.2.2    Product Portfolio
            12.3.2.3    Demographic Reach and Achievements
            12.3.2.4    Certifications
        12.3.3    Duke University Health System
            12.3.3.1    Company Overview
            12.3.3.2    Product Portfolio
            12.3.3.3    Demographic Reach and Achievements
            12.3.3.4    Certifications
        12.3.4    Lahey Clinic Foundation, Inc.
            12.3.4.1    Company Overview
            12.3.4.2    Product Portfolio
            12.3.4.3    Demographic Reach and Achievements
            12.3.4.4    Certifications
        12.3.5    Others
13    Industry Events and Developments

 

Additional Customisations Available

1    Manufacturing Process
    1.1    Overview
    1.2    Detailed Process Flow
    1.3    Operations Involved
2    Project Requirements and Cost Analysis
    2.1    Land, Location, and Site Development
    2.2    Construction
    2.3    Plant Machinery
    2.4    Cost of Raw Materials
    2.5    Packaging
    2.6    Transportation
    2.7    Utilities
    2.8    Manpower
    2.9    Other Capital Investments

 

List of Figures and Tables

1.    Global Giant Cell Arteritis Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Giant Cell Arteritis Treatment Historical Market: Breakup by Treatment Type (USD Billion), 2016-2020
3.    Global Giant Cell Arteritis Treatment Market Forecast: Breakup by Treatment Type (USD Billion), 2021-2026
4.    Global Giant Cell Arteritis Treatment Historical Market: Breakup by End Use (USD Billion), 2016-2020
5.    Global Giant Cell Arteritis Treatment Market Forecast: Breakup by End Use (USD Billion), 2021-2026
6.    Global Giant Cell Arteritis Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
7.    Global Giant Cell Arteritis Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
8.    North America Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
9.    North America Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
10.    Europe Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
11.    Europe Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
12.    Asia Pacific Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    Asia Pacific Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Latin America Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Latin America Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Middle East and Africa Giant Cell Arteritis Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Middle East and Africa Giant Cell Arteritis Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Global Giant Cell Arteritis Treatment Market Structure

Key Questions Answered in the Report

The global giant cell arteritis treatment market is expected to grow at a CAGR of 5.8%.

The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and the growing elderly population, are expected to aid the market growth.

The key trend in the industry is the growing investments in the R&D activities of the healthcare sector.

The major regional markets for giant cell arteritis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The major treatment types of giant cell arteritis in the market are corticosteroid therapy and adjuvant agents.

The leading end use sectors for giant cell arteritis treatment in the market are hospitals, clinics, and ASC’s, among others.

The key players in the market include Johns Hopkins Hospital, American College of Rheumatology, Duke University Health System, and Lahey Clinic Foundation, Inc., among others.

Analyst Review

The global giant cell arteritis treatment market is being driven by the rising prevalence of the disease. Aided by the growing elderly population, the market is expected to witness a healthy growth in the forecast period of 2021-2026, growing at a CAGR of 5.8%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on the treatment type, the market is broadly classified into corticosteroid therapy and adjuvant agents. By end use, the market can be categorised into hospitals, clinics, and ASC’s, among others. The major regional markets for giant cell arteritis treatment  are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the market include Johns Hopkins Hospital, American College of Rheumatology, Duke University Health System, and Lahey Clinic Foundation, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$ 3099     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$ 4099     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$ 5099     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Alternative Cancer Treatment Market Report and Forecast 2021-2026


Global Atrophic Scar Treatment Market Report and Forecast 2021-2026


Global Emphysema Treatment Market Report and Forecast 2021-2026



Global Retinitis Pigmentosa Treatment Market Report and Forecast 2020-2025


NEWSLETTER